Performs interpretation of molecular results to include next generation sequencing as well as electronic release of reviewed cases,
Reads and interprets laboratory data.
Performs quality control and assurance procedures and participates in departmental professional quality control and quality assurance activities.
Participates in several functions involved in day-to-day operations, including molecular case sign out responsibilities with full time availability to interact with our clients for Pre-Analytical, Analytical, and Post-Analytical questions.
Builds effective relationships with referring physicians and ensures excellent client follow-up.
Provides input in the decision- making process regarding utilization of state-of-the-art technologies, as well as innovative diagnostic or therapeutic testing in Hematopathology and Solid Tumors.
Participate in presentations at national scientific meetings, and in preparing publications for submission to peer-reviewed journals.
Requirements:
M.D. or D.O. degree required and M.D/Ph.D., or Ph.D. preferred; Board certification or board eligibility in Molecular Genetics Pathology through the American Board of Pathology and Medical Genetics or Clinical Molecular Genetics through the American Board of Medical Genetics.
At least five years of attending level experience.
At least two years' experience signing out Molecular Oncology cases working with NGS.
Board certification in Molecular Genetics Pathology through the American Board of Pathology OR Medical Genetics or Clinical Molecular Genetics through the American Board of Medical Genetics.